<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Richardson LW</submitter><funding>Australian Cancer Research Foundation</funding><funding>Wellcome Trust</funding><pagination>e202200306</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9804387</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(18)</volume><pubmed_abstract>Plasmepsin X (PMX) is an aspartyl protease that processes proteins essential for Plasmodium parasites to invade and egress from host erythrocytes during the symptomatic asexual stage of malaria. PMX substrates possess a conserved cleavage region denoted by the consensus motif, SFhE (h=hydrophobic amino acid). Peptidomimetics reflecting the P&lt;sub>3&lt;/sub> -P&lt;sub>1&lt;/sub> positions of the consensus motif were designed and showed potent and selective inhibition of PMX. It was established that PMX prefers Phe in the P&lt;sub>1&lt;/sub> position, di-substitution at the β-carbon of the P&lt;sub>2&lt;/sub> moiety and a hydrophobic P&lt;sub>3&lt;/sub> group which was supported by modelling of the peptidomimetics in complex with PMX. The peptidomimetics were shown to arrest asexual P. falciparum parasites at the schiz</pubmed_abstract><journal>ChemMedChem</journal><pubmed_title>Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity.</pubmed_title><pmcid>PMC9804387</pmcid><funding_grant_id>UNS19392</funding_grant_id><pubmed_authors>Hodder AN</pubmed_authors><pubmed_authors>Jarman KE</pubmed_authors><pubmed_authors>Triglia T</pubmed_authors><pubmed_authors>Ashton TD</pubmed_authors><pubmed_authors>Dans MG</pubmed_authors><pubmed_authors>Nguyen N</pubmed_authors><pubmed_authors>Favuzza P</pubmed_authors><pubmed_authors>Richardson LW</pubmed_authors><pubmed_authors>Ngo A</pubmed_authors><pubmed_authors>Cowman AF</pubmed_authors><pubmed_authors>Sleebs BE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity.</name><description>Plasmepsin X (PMX) is an aspartyl protease that processes proteins essential for Plasmodium parasites to invade and egress from host erythrocytes during the symptomatic asexual stage of malaria. PMX substrates possess a conserved cleavage region denoted by the consensus motif, SFhE (h=hydrophobic amino acid). Peptidomimetics reflecting the P&lt;sub>3&lt;/sub> -P&lt;sub>1&lt;/sub> positions of the consensus motif were designed and showed potent and selective inhibition of PMX. It was established that PMX prefers Phe in the P&lt;sub>1&lt;/sub> position, di-substitution at the β-carbon of the P&lt;sub>2&lt;/sub> moiety and a hydrophobic P&lt;sub>3&lt;/sub> group which was supported by modelling of the peptidomimetics in complex with PMX. The peptidomimetics were shown to arrest asexual P. falciparum parasites at the schiz</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-05-28T06:20:58.781Z</modification><creation>2025-04-06T09:03:17.821Z</creation></dates><accession>S-EPMC9804387</accession><cross_references><pubmed>35906744</pubmed><doi>10.1002/cmdc.202200306</doi></cross_references></HashMap>